Literature DB >> 22497974

Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells.

Houping Wang1, Sungsil Moon, Yuhuan Wang, Baoming Jiang.   

Abstract

Two live oral rotavirus vaccines have shown to be effective in protecting young children from severe illness in developed and middle income countries, but their efficacy is significantly lower in low income countries. One of the reasons for this lower efficacy may be mixed virus infection in the gut that is commonly encountered among infants in the developing world. We investigated whether multiple virus infection interferes with rotavirus replication and alters host response by comparing single and mixed enteric virus infections in Caco-2 cells. We observed a dramatic reduction in rotavirus replication and growth in mixed rotavirus, astrovirus and enterovirus infection compared to single rotavirus infection. By contrast, the levels of astrovirus and enterovirus RNA in mixed infection remained unchanged when compared to those of the corresponding single virus infection. We then examined cells with single or multiple virus infections for the expression of 10 cytokine genes and demonstrated elevated expressions for 7 (IFN-α, IFN-β, IFN-γ, TNF-α, IL-6, IL-8, and IL-17) in dual rotavirus and enterovirus or triple rotavirus, enterovirus and astrovirus-infected cells but only 3 (IFN-β, TNF-α, and IL-8) in dual rotavirus and astrovirus-infected cells. We further observed elevated levels of TLR4, TLR5, TLR7 and TLR9 mRNAs in cells with rotavirus and enterovirus or rotavirus, enterovirus and astrovirus infections when compared to single rotavirus infections. Our data suggest that rotavirus infection is susceptible to interference by other enteric viruses in the gut, which could result in reduced virus replication and contribute to lower immunogenicity and efficacy of oral rotavirus vaccines in low income countries. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22497974     DOI: 10.1016/j.virusres.2012.04.001

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  20 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Immune predictors of oral poliovirus vaccine immunogenicity among infants in South India.

Authors:  Nicholas C Grassly; Holm H Uhlig; Sudhir Babji; Punithavathy Manickavasagam; Yin-Huai Chen; Nithya Jeyavelu; Nisha Vincy Jose; Ira Praharaj; Chanduni Syed; Saravanakumar Puthupalayam Kaliappan; Jacob John; Sidhartha Giri; Srinivasan Venugopal; Beate Kampmann; Edward P K Parker; Miren Iturriza-Gómara; Gagandeep Kang
Journal:  NPJ Vaccines       Date:  2020-03-23       Impact factor: 7.344

3.  Timing of Birth as an Emergent Risk Factor for Rotavirus Hospitalization and Vaccine Performance in the Postvaccination Era in the United States.

Authors:  Benjamin Lopman; Rebecca Dahl; Minesh Shah; Umesh D Parashar
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

Review 4.  Rotavirus Vaccines: Effectiveness, Safety, and Future Directions.

Authors:  Eleanor Burnett; Umesh Parashar; Jacqueline Tate
Journal:  Paediatr Drugs       Date:  2018-06       Impact factor: 3.022

5.  Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.

Authors:  Devy M Emperador; Daniel E Velasquez; Concepcion F Estivariz; Ben Lopman; Baoming Jiang; Umesh Parashar; Abhijeet Anand; Khalequ Zaman
Journal:  Clin Infect Dis       Date:  2015-09-08       Impact factor: 9.079

Review 6.  Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.

Authors:  Daniel E Velasquez; Umesh Parashar; Baoming Jiang
Journal:  Expert Rev Vaccines       Date:  2017-12-29       Impact factor: 5.217

7.  Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.

Authors:  Mami Taniuchi; James A Platts-Mills; Sharmin Begum; Md Jashim Uddin; Shihab U Sobuz; Jie Liu; Beth D Kirkpatrick; E Ross Colgate; Marya P Carmolli; Dorothy M Dickson; Uma Nayak; Rashidul Haque; William A Petri; Eric R Houpt
Journal:  Vaccine       Date:  2016-05-03       Impact factor: 3.641

8.  Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.

Authors:  Shabihah Shahrudin; Cheng Chen; Shannon C David; Eve V Singleton; Justin Davies; Carl D Kirkwood; Timothy R Hirst; Michael Beard; Mohammed Alsharifi
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

9.  Detection of diarrhoea associated rotavirus and co-infection with diarrhoeagenic pathogens in the Littoral region of Cameroon using ELISA, RT-PCR and Luminex xTAG GPP assays.

Authors:  Rahinatou N Ghapoutsa; Maurice Boda; Rashi Gautam; Valantine Ngum Ndze; Akongnwi E Mugyia; Francois-Xavier Etoa; Michael D Bowen; Mathew D Esona
Journal:  BMC Infect Dis       Date:  2021-06-28       Impact factor: 3.090

10.  DNA-fragments are transcytosed across CaCo-2 cells by adsorptive endocytosis and vesicular mediated transport.

Authors:  Lene E Johannessen; Bjørn Spilsberg; Christer R Wiik-Nielsen; Anja B Kristoffersen; Arne Holst-Jensen; Knut G Berdal
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.